NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329,911 | -22.2% | 17,165 | +2.9% | 0.01% | -16.7% |
Q2 2023 | $424,056 | -21.1% | 16,682 | +12.2% | 0.01% | -25.0% |
Q1 2023 | $537,587 | -7.2% | 14,871 | +1.6% | 0.01% | -11.1% |
Q4 2022 | $579,506 | +36.0% | 14,634 | +60.0% | 0.01% | +12.5% |
Q3 2022 | $426,000 | -30.8% | 9,149 | -34.9% | 0.01% | -20.0% |
Q2 2022 | $616,000 | -30.5% | 14,060 | +14.8% | 0.01% | -23.1% |
Q1 2022 | $886,000 | -1.7% | 12,246 | +10.1% | 0.01% | +8.3% |
Q4 2021 | $901,000 | -49.3% | 11,118 | -27.2% | 0.01% | -52.0% |
Q3 2021 | $1,778,000 | -32.2% | 15,272 | -3.5% | 0.02% | -32.4% |
Q2 2021 | $2,624,000 | +29.7% | 15,829 | +9.1% | 0.04% | +19.4% |
Q1 2021 | $2,023,000 | -16.3% | 14,506 | +3.9% | 0.03% | -22.5% |
Q4 2020 | $2,417,000 | +20.4% | 13,960 | -3.2% | 0.04% | +2.6% |
Q3 2020 | $2,008,000 | +30.4% | 14,416 | +11.9% | 0.04% | +21.9% |
Q2 2020 | $1,540,000 | +65.9% | 12,888 | +38.9% | 0.03% | +39.1% |
Q1 2020 | $928,000 | -23.1% | 9,277 | -9.6% | 0.02% | -8.0% |
Q4 2019 | $1,206,000 | +19.8% | 10,264 | -12.4% | 0.02% | +13.6% |
Q3 2019 | $1,007,000 | +56.1% | 11,718 | +17.8% | 0.02% | +57.1% |
Q2 2019 | $645,000 | +15.6% | 9,949 | +11.4% | 0.01% | +7.7% |
Q1 2019 | $558,000 | +393.8% | 8,930 | +206.5% | 0.01% | +333.3% |
Q4 2018 | $113,000 | +61.4% | 2,914 | +281.4% | 0.00% | +50.0% |
Q3 2017 | $70,000 | +20.7% | 764 | -1.5% | 0.00% | 0.0% |
Q2 2017 | $58,000 | +176.2% | 776 | +248.0% | 0.00% | +100.0% |
Q1 2017 | $21,000 | – | 223 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |